12/16/2024 6:32 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 6:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 9:01 AM | Biora Therapeutics (Subject) HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/29/2024 3:43 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:37 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
10/29/2024 7:28 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:15 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
|
10/29/2024 7:19 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:24 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/23/2024 4:24 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
10/11/2024 3:52 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
10/11/2024 7:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 4:40 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/16/2024 3:30 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
09/13/2024 9:37 AM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024 5:02 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
09/03/2024 3:31 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
08/23/2024 4:06 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:08 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:11 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:13 PM | Biora Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/23/2024 4:03 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/21/2024 4:00 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 3:15 PM | Biora Therapeutics (Subject) DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
| Form SC 13G | |
08/14/2024 8:57 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 8:58 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
08/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 3:15 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 7:05 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 8:42 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
07/08/2024 8:15 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 8:00 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2024 5:04 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
07/01/2024 5:07 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:31 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Howe Jill Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Powell Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Wall Street Icon: “You must get on the right side of this thing” (Ad) I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants."
I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years. This market shakeup is going to be much more intense. |
06/06/2024 3:33 PM | Alter Jeffrey D. (Reporting) Biora Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Kotzin Brian L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/24/2024 3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024 7:43 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024 3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:48 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 3:45 PM | Biora Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 5:29 PM | Biora Therapeutics (Subject) Context Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
03/11/2024 7:11 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:43 PM | ARMISTICE CAPITAL, LLC (Filed by) Biora Therapeutics (Subject)
| Form SC 13G/A | |
01/16/2024 4:20 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/01/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
12/22/2023 4:19 PM | Biora Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |